Download presentation
Presentation is loading. Please wait.
1
Nat. Rev. Urol. doi:10.1038/nrurol.2017.163
Figure 3 Post hoc analysis of data from patients with stage II or III, intermediate-risk, nonstromal, nonepithelial Wilms tumour in the SIOP−2001 randomized controlled trial Figure 3 | Post hoc analysis of data from patients with stage II or III, intermediate-risk, nonstromal, nonepithelial Wilms tumour in the SIOP−2001 randomized controlled trial. Association of tumour volume and treatment with a | event-free survival (EFS) and b | overall survival (OS). Kaplan Meier curves. AV-2, actinomycin D, vincristine (27 weeks); AVD, actinomycin D, vincristine and doxorubicin. van den Heuvel-Eibrink, M. M. et al. (2017) Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol Nat. Rev. Urol. doi: /nrurol
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.